(Q28678660)

6 February 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871245%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

title

Preclinical studies of fibroblast growth factor receptor 3 as a therapeutic target in multiple myeloma (English)

2 references

6 February 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871245%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871245%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

7

Suzanne Trudel

2 references

6 February 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871245%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

author name string

Zhihua Li

2

2 references

6 February 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871245%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

Esther Masih-Khan

4

2 references

6 February 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871245%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

Hong Chang

5

2 references

6 February 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871245%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

Joshua L Paterson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871245%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

Jonathan B Pollett

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871245%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

A Keith Stewart

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871245%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

language of work or name

English

0 references

publication date

1 March 2004

2 references

6 February 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871245%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Haematology

20 November 2019

published in

2 references

6 February 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871245%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

volume

124

2 references

6 February 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871245%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

issue

5

2 references

6 February 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871245%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

page(s)

595-603

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871245%20AND%20SRC:MED&resulttype=core&format=json

Chromosome translocations in multiple myeloma

20 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04814.X

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

28 May 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04814.X

Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma

28 May 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04814.X

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

28 May 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04814.X

Analysis of FGFR3 gene mutations in multiple myeloma patients with t(4;14)

28 May 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04814.X

Signal transduction pathway of human fibroblast growth factor receptor 3. Identification of a novel 66-kDa phosphoprotein

28 May 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04814.X

The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells

28 May 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04814.X

Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors

28 May 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04814.X

A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGH/MMSET fusion transcript

28 May 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04814.X

Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: potential for pharmacodynamic monitoring of signal transduction inhibitors.

28 May 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04814.X

Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04814.X

STI571 as a targeted therapy for CML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04814.X

Mutation, SNP, and isoform analysis of fibroblast growth factor receptor 3 (FGFR3) in 150 newly diagnosed multiple myeloma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04814.X

Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04814.X

Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04814.X

Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04814.X

Molecular targets in acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04814.X

10.1111/J.1365-2141.2004.04814.X

21 January 2018

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871245%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017